Blogging today’s FDA stem cell meeting: Part 2 Clinics, Policy & Ethics

Jonathan-Kimmelman-FDA-e1473490111453

The FDA is holding its first 2016 stem cell meeting today and you can read about some impressions of the morning session of this meeting here. In this post, I’m focusing on the afternoon session, which has been mostly on policy and ethics, including on stem cell clinics. Jonathan Kimmelman from McGill University got the afternoon going …

Blogging today’s FDA stem cell meeting: Part 2 Clinics, Policy & Ethics Read More »